FFS
INFI

Founders Financial Securities’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Founders Financial Securities’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,602
Closed -$116K – 84
2015
Q2 		$116K Sell
10,602
-1,704
-14% -$21.9K 0.06% 61
2015
Q1 		$172K Buy
+12,306
New +$188K 0.09% 65

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Founders Financial Securities's INFI Position: Q3 2015 in Review

Founders Financial Securities sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2015, closing a stake of 10,602 shares — an estimated $116K sold.

Founders Financial Securities first reported a position in INFI in Q1 2015 and held it in 2 quarters. The position peaked at $172K in Q1 2015. 129 funds tracked by Wall St. Rank hold INFI as of Q3 2015.

  • Founders Financial Securities reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Founders Financial Securities sold 10,602 Infinity Pharmaceuticals, Inc. shares in Q3 2015, an estimated $116K.
  • Founders Financial Securities first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 2 quarters.
  • Founders Financial Securities's Infinity Pharmaceuticals, Inc. position peaked at $172K in Q1 2015.
  • 129 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2015.

Based on Founders Financial Securities's 13F filing for Q3 2015, filed 9 Oct 2015.